From January 24, 2024 to March 31, 2024, the company has repurchased 1,646,320 shares, representing 0.48% for CNY 27.78 million. With this, the company has completed the repurchase of 1,646,320 shares, representing 0.48% for CNY 27.78 million under the buyback announced on January 24, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
19.63 CNY | -1.85% | -4.71% | -9.58% |
06/05 | China Approves Tianyu Pharma's Heart Medication | MT |
26/04 | Zhejiang Tianyu Pharmaceutical Co., Ltd. Announces Profit Distribution Proposal for 2023 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-9.58% | 93Cr | |
+17.43% | 4.22TCr | |
+15.37% | 2.13TCr | |
+19.62% | 1.52TCr | |
+19.84% | 1.44TCr | |
+51.59% | 1.27TCr | |
-0.05% | 678.76Cr | |
-12.40% | 660.77Cr | |
-8.87% | 572.55Cr | |
+14.28% | 565.61Cr |
- Stock Market
- Equities
- 300702 Stock
- News Zhejiang Tianyu Pharmaceutical Co., Ltd.
- Tranche Update on Zhejiang Tianyu Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on January 24, 2024.